Standard BioTools reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Standard BioTools using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $-0.09 | $-0.04 | -125.0 % |
| Q2 | 2025-08-11 | $-0.09 | $-0.05 | -80.0 % |
| Q1 | 2025-05-06 | $-0.07 | $-0.04 | -75.0 % |
| Q4 | 2025-02-26 | $-0.09 | $-0.03 | -200.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $19.55M | $18.00M | 8.62 % |
| Q2 | 2025-08-11 | $41.96M | $39.83M | 5.35 % |
| Q1 | 2025-05-06 | $40.80M | $40.10M | 1.75 % |
| Q4 | 2025-02-26 | $46.72M | $43.03M | 8.57 % |
Standard BioTools (LAB) is scheduled to report earnings on February 25, 2026. The last reported earnings were for reported on November 4, 2025 for Q3.
The Actual EPS was $-0.09, which missed the estimate of $-0.04.
The Actual Revenue was $19.6M, which beat the estimate of $18M.
Browse earnings estimates, EPS, and revenue on all stocks.